Eli Lilly and (LLY) Revenue — Quarter Ended Mar 31, 2023
Eli Lilly reported a decrease in revenue for the first quarter. The figure was down compared to the previous quarter and the same period last year.
Key takeaway
Quarter ended Mar 31, 2023 · FY2023 Q1
Eli Lilly reported a decrease in revenue for the first quarter. The figure was down compared to the previous quarter and the same period last year.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$7B
Revenue reported for this quarter.
Quarter-over-quarter
-4.7%
Change from the immediately preceding quarter.
Year-over-year
-10.9%
Change from the comparable year-ago quarter.
Trailing four quarters
$27.7B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Jun 30, 2022 | $6.5B | -3.7% |
| Sep 30, 2022 | $6.9B | +2.5% |
| Dec 31, 2022 | $7.3B | -8.7% |
| Mar 31, 2023 | $7B | -10.9% |
Revenue performance
Revenue declined sequentially and on an annual basis, marking a continuation of the downward trend observed in recent quarters.
Quarterly comparison
The sequential decline was moderate, while the year-over-year decline was more pronounced.
What to watch
The trajectory of revenue growth in upcoming quarters will be a key focus.